Trends in glycaemic control and morbidity over 10 years in patients with type 1 diabetes mellitus at Inkosi Albert Luthuli Central Hospital

References

• The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993;329(14):977–986.
   PubMed Web of Science ®Google Scholar
• Brinchmann-Hansen O, Dahl-Jorgensen K, Sandvik L, et al. Blood glucose concentrations and progression of diabetic retinopathy: the seven year results of the Oslo study. BMJ (Clin Res Ed). 1992;304(6818):19–22.
   PubMedGoogle Scholar
• Feldt-Rasmussen B, Mathiesen ER, Deckert T. Effect of two years of strict metabolic control on progression of incipient nephropathy in insulin-dependent diabetes. Lancet. 1986;328(8519):1300–1304.
   Google Scholar
• Holman RR, Dornan TL, Mayon-White V, et al. Prevention of deterioration of renal and sensory-nerve function by more intensive management of insulin-dependent diabetic patients. A two-year randomised prospective study. Lancet. 1983;321(8318):204–208.
   Google Scholar
• Nathan DM, Bayless M, Cleary P, et al. Diabetes control and complications trial/epidemiology of diabetes interventions and complications study at 30 years: advances and contributions. Diabetes. 2013;62(12):3976–3986.
   PubMed Web of Science ®Google Scholar
• The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study Research Group. Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med. 2005;353(25):2643–2653.
   PubMed Web of Science ®Google Scholar
• Fullerton B, Jeitler K, Seitz M, et al. Intensive glucose control versus conventional glucose control for type 1 diabetes mellitus. Cochrane Database Syst Rev. 2014;2014(2):Cd009122.
   Google Scholar
• Sperling M. ISPAD clinical practice Consensus guidelines 2014. Pediatr Diabetes. 2014;15(Suppl 20):1–290.
   Google Scholar
• Amod A, Dave J, Mohammed N, et al. Guidelines for the management of type 2 diabetes mellitus SEMDSA type 2 diabetes guidelines expert committee. JEMDSA. 2017;22(Supplement 1):S1–S1962019.
   Google Scholar
• Chamberlain JJ, Rhinehart AS, Shaefer CF Jr, et al. Diagnosis and management of diabetes: synopsis of the 2016 American diabetes association standards of medical care in diabetes. Ann Intern Med. 2016;164(8):542–552.
   PubMed Web of Science ®Google Scholar
• Wood JR, Miller KM, Maahs DM, et al. Most youth with type 1 diabetes in the T1D exchange clinic registry do not meet American diabetes Association or international society for Pediatric and Adolescent diabetes clinical guidelines. Diabetes Care. 2013;36(7):2035–2037.
   PubMed Web of Science ®Google Scholar
• Mannucci E, Monami M, Dicembrini I, et al. Achieving HbA1c targets in clinical trials and in the real world: a systematic review and meta-analysis. J Endocrinol Invest. 2014;37(5):477–495.
   PubMed Web of Science ®Google Scholar
• Amod A, Riback W, Schoeman H. Diabetes guidelines and clinical practice: is there a gap? The South African cohort of the international diabetes management practices study: original research. J Endocrinol, Metab Diabetes S Afr. 2012;17(2):85–90.
   Google Scholar
• Marshall SL, Edidin DV, Arena VC, et al. Glucose control in Rwandan youth with type 1 diabetes following establishment of systematic, HbA1c based, care and education. Diabetes Res Clin Pract. 2015;107(1):113–122.
   PubMed Web of Science ®Google Scholar
• Nordwall M, Bojestig M, Arnqvist HJ, et al. Declining incidence of severe retinopathy and persisting decrease of nephropathy in an unselected population of type 1 diabetes-the linkoping diabetes complications study. Diabetologia. 2004;47(7):1266–1272.
   PubMed Web of Science ®Google Scholar
• Yokoyama H, Araki S-i, Kawai K, et al. Declining trends of diabetic nephropathy, retinopathy and neuropathy with improving diabetes care indicators in Japanese patients with type 2 and type 1 diabetes (JDDM 46). BMJ Open Diabetes Research and Care. 2018;6(1):e000521.
   PubMed Web of Science ®Google Scholar
• Pambianco G, Costacou T, Ellis D, et al. The 30-year natural history of type 1 diabetes complications. Diabetes. 2006;55(5):1463–1469.
   PubMed Web of Science ®Google Scholar
• Fleming JS, Zivanovic MA, Blake GM, et al. Guidelines for the measurement of glomerular filtration rate using plasma sampling. Nucl Med Commun. 2004;25(8):759–769.
   PubMed Web of Science ®Google Scholar
• Levey AS, Stevens LA, Schmid CH, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150(9):604–612.
   PubMed Web of Science ®Google Scholar
• Jones AG, Hattersley AT. The clinical utility of C-peptide measurement in the care of patients with diabetes. Diabetic Med. 2013;30(7):803–817.
   PubMed Web of Science ®Google Scholar
• American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2014;37(Supplement 1):S81–S90.
   PubMed Web of Science ®Google Scholar
• Kidney Disease: Improving Global Outcomes (KDIGO). KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int Suppl;2013;3(1):1–150.
   Web of Science ®Google Scholar
• James PA, Oparil S, Carter BL, et al. Evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the eighth joint national committee (JNC 8)2014 guideline for management of high blood pressure2014 guideline for management of high blood pressure. JAMA. 2014;311(5):507–520.
   PubMed Web of Science ®Google Scholar
• Solomon SD, Chew E, Duh EJ, et al. Diabetic retinopathy: a position statement by the American diabetes Association. Diabetes Care. 2017;40(3):412–418.
   PubMed Web of Science ®Google Scholar
• Hirshberg B, Katz A. Cardiovascular outcome studies with novel Antidiabetes agents: scientific and operational considerations. Diabetes Care. 2013;36(Supplement 2):S253–S258.
   PubMedGoogle Scholar
• McKnight JA, Wild SH, Lamb MJE, et al. Glycaemic control of type 1 diabetes in clinical practice early in the 21st century: an international comparison. Diabetic Med. 2015;32(8):1036–1050.
   PubMed Web of Science ®Google Scholar
• Heald AH, Livingston M, Fryer A, et al. Route to improving type 1 diabetes mellitus glycaemic outcomes: real-world evidence taken from the National Diabetes Audit. Diabetic Med. 2018;35(1):63–71.
   PubMed Web of Science ®Google Scholar
• Maahs DM, Dabelea D, D’Agostino RB Jr, et al. Glucose control Predicts 2-year change in lipid Profile in youth with type 1 diabetes. J Pediatr. 2013;162(1):101–107. e101.
   PubMed Web of Science ®Google Scholar
• Rawshani A, Rawshani A, Franzén S, et al. Mortality and cardiovascular disease in type 1 and type 2 diabetes. N Engl J Med. 2017;376(15):1407–1418.
   PubMed Web of Science ®Google Scholar
• Jensen MT, Andersen HU, Rossing P, et al. Statins are independently associated with increased HbA1c in type 1 diabetes–the thousand & 1 study. Diabetes Res Clin Pract. 2016;111:51–57.
   PubMed Web of Science ®Google Scholar
• Collado-Mesa F, Colhoun HM, Stevens LK, et al. Prevalence and management of hypertension in type 1 diabetes mellitus in Europe: the EURODIAB IDDM complications study. Diabetic Med. 1999;16(1):41–48.
   PubMed Web of Science ®Google Scholar
• Maahs DM, Kinney GL, Wadwa P, et al. Hypertension prevalence, Awareness, treatment, and control in an adult type 1 diabetes population and a comparable general population. Diabetes Care. 2005;28(2):301.
   PubMed Web of Science ®Google Scholar
• Gomes MB, Tannus LRM, Matheus A, et al. Prevalence, awareness, and treatment of hypertension in patients with type 1 diabetes: a nationwide multicenter study in Brazil. Int J Hypertens. 2013;2013:1–8.
   Google Scholar
• Wandai ME, Norris SA, Aagaard-Hansen J, et al. Geographical influence on the distribution of the prevalence of hypertension in South Africa: a multilevel analysis. Cardiovasc J Afr. 2019;30:1–8.
   Google Scholar
• Romero-Aroca P, Navarro-Gil R, Valls-Mateu A, et al. Differences in incidence of diabetic retinopathy between type 1 and 2 diabetes mellitus: a nine-year follow-up study. Br J Ophthalmol. 2017;101(10):1346–1351.
   PubMed Web of Science ®Google Scholar
• Wang SY, Andrews CA, Herman WH, et al. Incidence and risk factors for developing diabetic retinopathy among youths with type 1 or type 2 diabetes throughout the United States. Ophthalmology. 2017;124(4):424–430.
   PubMed Web of Science ®Google Scholar
• Hainsworth DP, Bebu I, Aiello LP, et al. Risk factors for retinopathy in type 1 diabetes: The DCCT/EDIC study. Diabetes Care. 2019;42:dc182308.
   Web of Science ®Google Scholar
• Lloyd CE, Klein R, Maser RE, et al. The progression of retinopathy over 2 years: the Pittsburgh epidemiology of diabetes complications (EDC) study. J Diabetes Complicat. 1995;9(3):140–148.
   PubMed Web of Science ®Google Scholar
• Piscitelli P, Viazzi F, Fioretto P, et al. Predictors of chronic kidney disease in type 1 diabetes: a longitudinal study from the AMD Annals initiative. Sci Rep. 2017;7(1):3313–3313.
   PubMedGoogle Scholar
• Group DER, de Boer IH, Sun W, et al. Intensive diabetes therapy and glomerular filtration rate in type 1 diabetes. N Engl J Med. 2011;365(25):2366–2376.
   PubMed Web of Science ®Google Scholar
• Soedamah-Muthu SS, Fuller JH, Mulnier HE, et al. High risk of cardiovascular disease in patients with type 1 diabetes in the U.K. Diabetes Care. 2006;29(4):798–804.
   PubMed Web of Science ®Google Scholar
• Akinboboye O, Idris O, Akinboboye O, et al. Trends in coronary artery disease and associated risk factors in sub-Saharan Africans. J Hum Hypertens. 2003;17(6):381–387.
   PubMed Web of Science ®Google Scholar